A Case-CrossovEr Study deSign to Inform Tailored Interventions to Prevent Disease Progression in Acute Pancreatitis

UnknownOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

June 1, 2024

Conditions
Pancreatitis, AcuteAlcohol DrinkingHealth Behavior
Trial Locations (5)

15260

University of Pittsburg, Pittsburgh

43210

Ohio State University, Columbus

90033

University of Southern California, Los Angeles

90034

Cedars-Sinai Medical Center, Los Angeles

Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

University of Pittsburgh

OTHER

collaborator

Alcohol Research Group

OTHER

collaborator

Ohio State University

OTHER

collaborator

VA Greater Los Angeles Healthcare System

FED

lead

Cedars-Sinai Medical Center

OTHER

NCT04743323 - A Case-CrossovEr Study deSign to Inform Tailored Interventions to Prevent Disease Progression in Acute Pancreatitis | Biotech Hunter | Biotech Hunter